Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02745197

A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer

Factors That Regulate Components of a Nutritional Supplement to Support Skeletal Muscle in Cancer Patients

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Alberta · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

This study evaluates a nutritional supplement in the treatment of pancreatic cancer in adults. Half of the participants will receive the nutritional supplement, while the other half will receive a placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNutritional SupplementParticipants will take 2 capsules, containing the nutritional supplement, 3 times per day.
DIETARY_SUPPLEMENTPlaceboParticipants will take 2 capsules, containing a placebo, 3 times per day.

Timeline

Start date
2017-05-01
Primary completion
2018-10-01
Completion
2018-10-01
First posted
2016-04-20
Last updated
2024-09-19

Source: ClinicalTrials.gov record NCT02745197. Inclusion in this directory is not an endorsement.

A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer (NCT02745197) · Clinical Trials Directory